PHASE 1 AND 2 TRIALS OF COMBINATION THERAPY WITH GEMCITABINE AND CANDESARTAN IN ADVANCED PANCREATIC CANCER

被引：0
|
作者：
Nakai, Y. [1 ]
Isayama, H. [1 ]
Ijichi, H. [1 ]
Sasaki, T. [1 ]
Ito, Y. [2 ]
Matsubara, S. [3 ]
Yagioka, H. [4 ]
Nagano, R. [5 ]
Kawakubo, K. [1 ]
Kogure, H. [1 ]
Yamamoto, N. [1 ]
Sasahira, N. [1 ]
Hirano, K. [1 ]
Tada, M. [1 ]
Koike, K. [1 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138654, Japan
[2] Japanese Red Cross Med Ctr, Dept Gastroenterol, Tokyo, Japan
[3] Tokyo Metropolitan Police Hosp, Dept Gastroenterol, Tokyo, Japan
[4] JR Tokyo Gen Hosp, Dept Gastroenterol, Tokyo, Japan
[5] Kanto Cent Hosp, Dept Gastroenterol, Yokohama, Kanagawa, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
    Li, Qin
    Yan, Han
    Liu, Wenting
    Zhen, Hongchao
    Yang, Yifan
    Cao, Bangwei
    PLOS ONE, 2014, 9 (08):
  • [42] Combination Therapy of Portal Vein Resection and Adjuvant Gemcitabine Improved Prognosis of Advanced Pancreatic Cancer
    Nakamura, Masafumi
    Kayashima, Tadashi
    Fujiwara, Kenji
    Nagayoshi, Yosuke
    Kono, Hiroshi
    Ohtsuka, Takao
    Takahata, Shunichi
    Mizumoto, Kazuhiro
    Tanaka, Masao
    HEPATO-GASTROENTEROLOGY, 2013, 60 (122) : 354 - 357
  • [43] Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A systematic review and meta-analysis of randomized trials
    Ciliberto, Domenico
    Botta, Cirino
    Correale, Pierpaolo
    Mazzanti, Roberto
    Mantovani, Giovanni
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Efficacy and safety of gemcitabine-targeted agent combination therapy in advanced pancreatic cancer: a meta-analysis of randomized controlled trials
    Li, Xinyan
    Li, Weichen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (12): : 12902 - 12916
  • [45] Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
    Brodowicz, T
    Wolfram, RM
    Köstler, WJ
    Tomek, S
    Vaclavik, I
    Steger, GG
    Teleky, B
    Függer, R
    Jakesz, R
    Zielinski, CC
    ANTI-CANCER DRUGS, 2000, 11 (08) : 623 - 628
  • [46] Phase I study of nab-paclitaxel and gemcitabine combination in patients with advanced pancreatic cancer
    Drengler, R. L.
    Smith, L. S.
    Wood, T. E.
    Borad, M. J.
    Ramanathan, R. K.
    Laheru, D. A.
    Hidalgo, M.
    Von Hoff, D. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer
    Yaman Suleiman
    Amit Mahipal
    David Shibata
    Erin M. Siegel
    Helen Jump
    William J. Fulp
    Gregory M. Springett
    Richard Kim
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 481 - 487
  • [48] Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results
    Cardin, Dana B.
    Goff, Laura W.
    Chan, Emily
    Whisenant, Jennifer G.
    Ayers, G. Dan
    Takebe, Naoko
    Arlinghaus, Lori R.
    Yankeelov, Thomas E.
    Berlin, Jordan
    Merchant, Nipun
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (03) : 442 - 450
  • [49] A phase II trial of cationic liposomal paclitaxel in combination with gemcitabine in patients with advanced pancreatic cancer
    Loehr, J. M.
    Bodoky, G.
    Foelsch, U.
    Maerten, A.
    Lilla, C.
    Meyer, I.
    Osinsky, D.
    Szanto, J.
    Lutz, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 386 - 386
  • [50] Cationic liposomal paclitaxel in combination with gemcitabine in patients with advanced pancreatic cancer: A phase II trial
    Loehr, M.
    Bodoky, G.
    Folsch, U.
    Marten, A.
    Karrasch, M.
    Lilla, C.
    Meyer, I.
    Osinsky, D.
    Szanto, J.
    Lutz, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345